Notice of the 2025 Annual General Meeting of Generic Sweden AB
April 15, 2025
NOTICE OF THE ANNUAL SHAREHOLDERS' MEETING
The shareholders of Generic Sweden AB (publ) are hereby invited to the annual shareholders’ meeting on Thursday, May 15, 2025, at 5:30 p.m. at the Waterfront Building, Klarabergsviadukten 63, in Stockholm.
RIGHT TO PARTICIPATION
Any person who is listed as a shareholder in the share register maintained by Euroclear Sweden AB as of Wednesday, May 7, 2025, and who has notified the company of their intention to attend no later than Friday, May 9 May 2025.
Shareholders whose shares are held in a nominee account through a bank or other nominee must, in addition to registering for the meeting, have the shares registered in their own name so that they are included in the share register as of Wednesday, May 7, 2025. Such registration may be temporary (known as “voting rights registration”) and must be requested from the custodian in accordance with the custodian’s procedures at least as far in advance as the custodian determines. Voting rights registrations completed by the custodian no later than Friday, May 9, 2025, will be taken into account when compiling the shareholder register.
REGISTRATION FOR PARTICIPATION
Notification may be submitted in writing to Generic Sweden AB (publ), Box 190, 101 23 Stockholm (mark the envelope “Annual General Meeting”), via email to info@generic.se, by phone at 08-601 38 00, or by fax at 010-150 38 00. The registration must include name, personal or organization number, number of shares, daytime phone number, and, if applicable, the number of assistants (no more than two) the shareholder intends to bring to the meeting. If a shareholder intends to be represented by a proxy, the power of attorney and other authorization documents should be attached to the registration. A proxy form is available at www.generic.se, and can also be requested from the company at the address listed above.
PROPOSED AGENDA
- Opening
- Election of a Chairperson at the Meeting
- Preparation and Approval of the Voter Register
- Approval of the Agenda
- Election of one or two tellers
- Determination of Whether the Meeting Was Duly Convened
- Presentation of the Annual Report and Auditor’s Report, as well as the Consolidated Financial Statements and the Consolidated Auditor’s Report
- Resolutions regarding
(i) the adoption of the income statement and balance sheet, as well as the consolidated income statement and consolidated balance sheet,
(ii) allocation of the company’s net income in accordance with the adopted balance sheet, and
(iii) the discharge of the members of the Board of Directors and the Chief Executive Officer from liability - Determination of the number of board members, alternate board members, auditors, and alternate auditors
- Determination of Remuneration for the Board of Directors and the Auditor
- Election of the Board of Directors, the Chair of the Board, and the Auditor
- Resolution on the Nominating Committee
- Conclusion
DIVIDEND (ITEM 8 (ii))
The Board of Directors and the CEO propose that the Annual General Meeting approve a dividend of 1.60 kronor per share for the 2024 fiscal year. The proposed record date for the dividend is Monday, May 19, 2025. If the Annual General Meeting approves the proposal, the dividend is expected to be distributed through Euroclear Sweden AB on Thursday May May 22, 2025. The last day of trading in the company’s shares with dividend rights is Thursday, May 15, 2025.
BOARD OF DIRECTORS, ETC. (ITEMS 2 AND 9–11)
The Nominating Committee, consisting of Hans Krantz (representing KH Förvaltning AB and HAG Förvaltning AB), Emil Hjalmarsson (representing Grenspecialisten AB), and John Löfström, proposes the following:
Chair of the Meeting: Attorney Erik Sjöman, Attorney Christian Lindhé, or Attorney Martin Madsen Svanberg (all of Vinge Law Firm), with the final selection to be determined based on their availability on that day.
The number of board members and alternates: five regular members with no alternates.
Board of Directors’ compensation: SEK 200,000 (unchanged) to the Chairman of the Board and SEK 100,000 (unchanged) to each of the other members who are not employees of the company.
Board of Directors: Re-election of Hans Krantz, Stefan Widén, Bengt-Arne Molin, Erik Ivarsson, and Johanna Berlinde for the term until the next annual shareholders' meeting, with Erik Ivarsson as the new chairman of the board.
Number of auditors and alternate auditors: one auditor with no alternates.
Auditor's fees: billed on a running basis.
Auditor: Reappointment of Öhrlings PricewaterhouseCoopers AB (Christian Lamrin is designated as the principal auditor).
Shareholders representing approximately 53 percent of the company’s shares and votes have stated that they will support the Nominating Committee’s proposals, including the proposal to elect Erik Ivarsson as the new chairman of the board.
NOMINATING COMMITTEE (ITEM 12)
The Nomination Committee proposes that the Annual General Meeting instruct the Chairman of the Board to convene, based on the shareholdings as of the end of September 2025, a Nomination Committee consisting of one representative from each of the company’s three largest shareholders. The Chair shall be elected by the members of the Nomination Committee. The Nomination Committee shall remain in office until the next Nomination Committee has been appointed. In the event that a member of the Nomination Committee no longer represents one of the company’s three largest shareholders, the Nomination Committee may remove that member from office. In the event that a member of the Nomination Committee resigns or is dismissed, the Nomination Committee may appoint another representative of the major shareholders to replace such member. No compensation is paid for work on the Nomination Committee. However, in the event that the Nomination Committee incurs external costs for the recruitment or evaluation of members, such costs shall be reimbursed by the company. The Nomination Committee shall prepare proposals to be presented to the 2026 Annual General Meeting regarding (i) the chair of the meeting, (ii) the election of the Board of Directors, (iii) Board remuneration, (iv) auditor’s fees, (v) the election of the auditor, and (vi) the appointment of the Nomination Committee for the next Annual General Meeting.
______________________
DOCUMENTATION, ETC.
The annual report and other supporting documentation will be available at the company’s office, Klarabergsviadukten 63,Stockholm and on the company’s website, www.generic.se, no later than three weeks before the meeting and will be sent free of charge to shareholders who request them and provide their mailing address. Shareholders are reminded of their right to request information pursuant to Chapter 7, Section 32 of the Swedish Companies Act.
PROCESSING OF PERSONAL DATA
For information on how your personal data is processed, please refer to the privacy policy available on Euroclear Sweden AB’s website, www.euroclear.com/dam/ESw/Legal/Integritetspolicy-bolagsstammor-svenska.pdf. If you have any questions regarding our processing of personal data, please contact us via email at info@generic.se. Generic Sweden AB (publ) has corporate registration number 556472-3632 and is headquartered in Stockholm.
Stockholm in April 2025
The Board of Directors of Generic Sweden AB (publ)
Susanne Lundin
CFO
08-601 38 00
susanne.lundin@generic.se
About Generic
Generic is a technology company that provides messaging services across all sectors. Generic offers a platform for digital communication services that can be integrated into customers’ internal or external communication flows. The services are provided through a CPaaS (Communication Platform as a Service) model that meets the highest standards for security and reliability. Generic’s customers span all sectors, with a particular focus on alarm and security, healthcare and e-health, as well as e-commerce and logistics. The company was founded in 1993 and is headquartered in Stockholm. Generic reported revenue of approximately 177 MSEK in 2024 and has 22 employees. The stock is traded on the NASDAQ First North Growth Market under the ticker symbol GENI. Mangold Fondkommission AB is the company’s Certified Adviser. 08/503 015 50. ca@mangold.se. Reference is made to www.generic.se/finansiellarapporter. Additional information about the company is available at www.generic.se